Cite
HARVARD Citation
Chen, D. et al. (2018). FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer. Medicine. 97 (10), p. . [Online].